All Posts

GP practices are under constant pressure. From increasing patient demand to administrative workload and limited resources, it can be difficult to find new ways to generate income without adding strain to daily operations. One opportunity that is often overlooked is participation in clinical trial recruitment. By partnering with organisations like TrialChoices, GP practices can play an active role in medical research while also creating a new, sustainable revenue stream. Why C

Clinical trials are no longer limited by geography, but they are still limited by access. Global research teams can design multi-country studies, collaborate across borders, and scale faster than ever before. Yet one challenge remains constant: finding the right patients, at the right time, in the right locations. That is where real-time access to UK patient data changes everything. Instead of relying on outdated estimates or slow recruitment methods, research teams can make

Clinical trial delays rarely begin where people expect. Most teams assume recruitment problems start when patients are slow to respond, sites struggle to enrol, or outreach campaigns underperform. But in reality, many delays are already locked in long before the first patient is contacted. The biggest hidden cost in clinical research is not just slow recruitment. It is poor early visibility — not knowing how many suitable patients are actually accessible, where they are locat

Clinical trial recruitment looks simple on paper. Define the criteria, identify the right patients, make contact, and move the study forward. In practice, it rarely works that neatly. One of the biggest reasons is scale. When a study depends on finding a very specific patient group within a limited time frame, access matters. That is why TrialChoices’ model stands out. The organisation positions itself around connecting global research with UK patients, with direct access to

Clinical trials play a crucial role in advancing healthcare, offering new insights into treatments, preventive measures, and innovative care approaches. For GP practices, involvement in clinical trials provides unique opportunities to improve patient care while staying at the forefront of medical innovation. Overview of Clinical Trials Clinical trials are structured studies designed to test new treatments, interventions, or healthcare approaches. While many people think of t

Large-scale patient access is essential for conducting faster, more diverse, and more efficient clinical trials. In the UK, the combination of GP practices, research networks, and digital recruitment systems allows sponsors and primary care providers to reach eligible participants quickly while maintaining compliance and high-quality data. Accessing UK patient populations for clinical trials at scale ensures studies can meet enrollment targets, improve representation, and del

Clinical trial referrals are a key part of advancing medical research and improving patient care. For GPs, understanding how to start referring patients to trials can have a major impact on healthcare outcomes. Step-by-step guidance ensures that GPs can confidently support research while providing new treatment opportunities to their patients. GP participation is critical because primary care providers are uniquely positioned to identify suitable patients, explain the trial p

GP practices across the UK are facing growing financial pressures as patient demand increases and operational costs continue to rise. At the same time, the healthcare industry is seeing a strong demand for patient recruitment in clinical research. This has created a new opportunity for primary care providers. Clinical trial recruitment allows practices to play a valuable role in connecting eligible patients with research opportunities. With the right partnerships and process

Recruitment is often the biggest bottleneck in clinical trials, slowing timelines and increasing costs for sponsors. Traditional trial designs that overlook patient needs can lead to low enrolment, high drop-out rates, and unrepresentative study populations. Making clinical trials patient-centric is not just about improving retention — it is also essential for more efficient recruitment, greater diversity, and overall trial success. What Does “Patient-Centric Clinical Tria

Global clinical trials are essential for developing new therapies and advancing medical knowledge, yet 85% of clinical trials face delays that slow progress and increase costs. Delays in patient recruitment are one of the primary factors, but they are only part of a complex web of challenges affecting trial timelines. Efficient trial recruitment is critical not only for sponsors but also for patients waiting for innovative treatments. Multifaceted Drivers of Delay While pati

Identifying “trial-ready” patients early is critical for improving clinical trial success. Faster recruitment, cost-efficiency, and more representative data all depend on connecting eligible patients with the right studies at the right time. Consultants and recruitment specialists act as the bridge between trial sponsors and patients, ensuring that both sides benefit. What “Trial-Ready” Really Means A trial-ready patient is one who meets eligibility criteria, demonstrates wi

Clinical trials are essential for advancing healthcare, but successful trials depend on timely patient recruitment and accurate data. In the UK, general practitioners (GPs) play a pivotal role in connecting patients to research opportunities. However, GPs are already managing heavy patient loads, administrative tasks, and complex caseloads. So how can GPs support clinical trials without adding workload? Understanding this balance is crucial for designing patient-centric studi

Key Performance Indicators, or KPIs, are critical for ensuring that any clinical trial runs smoothly, stays on budget, and delivers meaningful results for patients. In the context of UK-based clinical trials, understanding and tracking recruitment KPIs is even more essential. The UK’s unique regulatory landscape, combined with demographic and geographic factors, can create challenges for patient recruitment and trial management. Trial Recruitment KPIs KPIs are not just numbe

Patient recruitment is a critical bottleneck in multi-site clinical trials, particularly within the UK context. Delays in enrolling participants can significantly impact trial timelines, escalate costs, and compromise data quality. To mitigate these challenges, it's essential to develop a scalable recruitment strategy that is adaptable across diverse sites and patient populations. Understanding the Complexities of Multi-Site Recruitment Geographic Diversity Recruiting patient

Clinical trials are essential for developing effective treatments and advancing medical knowledge. However, a significant gap exists in the representation of certain patient groups, particularly underrepresented populations, in these studies. This lack of diversity can lead to skewed results and treatments that may not be universally effective. Addressing this issue requires understanding the barriers to participation and implementing strategies to engage these populations ef

In the UK, clinical trials are essential for advancing medical research and bringing new treatments to patients. However, a significant challenge persists: patient recruitment. A recent report from the Association of the British Pharmaceutical Industry (ABPI) highlights that recruitment to industry clinical trials in England fell by 9.2% in 2023/2024 compared to the previous year. This decline leads to delayed drug approvals, increased costs, and slower access to innovative t

Clinical trials play a vital role in advancing medical research and developing new treatments that improve patient outcomes. Understanding how patients are chosen for a clinical trial provides insight into how researchers ensure both safety and accuracy throughout the study. Each participant must meet a defined set of requirements before being accepted, which guarantees that the research findings are both ethical and scientifically valid. If you have ever wondered how clinica

Clinical research plays a vital role in driving medical innovation, helping scientists and healthcare professionals discover new treatments, prevent diseases, and improve patient outcomes. Every clinical trial relies on one essential process that determines its success — patient recruitment . Without the right participants, even the most promising studies can face delays or fail to produce meaningful results. This is why effective recruitment strategies are at the heart of a

The landscape of clinical research in the UK is rapidly changing, and General Practitioners (GPs) are playing a bigger role than ever before. As the first point of contact in primary care , GPs hold a unique position in identifying, guiding, and supporting patients who could benefit from taking part in research. Integrating GPs into clinical studies not only enhances patient access but also improves study design , data accuracy, and overall healthcare outcomes. With their de

Participating in a clinical trial is an incredible opportunity to contribute to medical breakthroughs while potentially accessing innovative treatments not yet available to the public. Before joining, every participant goes through a detailed screening process that ensures safety, eligibility, and the scientific integrity of the study. Purpose Beyond Eligibility The screening phase is more than a formality. It’s designed to protect your health while ensuring the clinical tr